$CE · Celanese Corp
Celanese filed its Q3 FY2026 10-Q, reporting net income attributable to Celanese of $74M ($0.67 diluted EPS) versus a $1.357B loss in Q3 2025. Revenue grew 5.7% YoY to $2.556B, with Acetyl Chain up 14.8% and Engineered Materials down 1.2%. The prior-year loss was driven by a $1.486B asset impairment charge that did not recur.
- Q3 net income attributable to Celanese: $74M vs. a $1.357B loss in Q3 2025, driven by absence of prior-year $1.486B asset impairment.
- Q3 revenue rose 5.7% YoY to $2.556B, with Acetyl Chain up 14.8% to $1.188B and Engineered Materials down 1.2% to $1.368B.
- Q3 operating margin was 7.7% vs. negative 52.7% a year ago; gross margin improved to 21.1% from 21.5%.
- Nine-month operating cash flow declined to $823M from $894M; the company repaid $1.089B in long-term debt.
- Restructuring charges of $30M in Q3 tied to facility closures in Lanaken (Belgium), Ulsan (South Korea), and Sakra (Singapore).
Markets closed — no regular-session reaction yet; extended-hours move not captured here. The $5.53B market cap company posted a clean return to profitability after a year-ago impairment-driven loss, which could be received positively.
The clean YoY swing from a $1.357B loss to $74M profit signals the impairment overhang is cleared, but ongoing restructuring and tariff uncertainty keep the recovery fragile.
The Acetyl Chain segment drove the quarter with 14.8% YoY revenue growth, while Engineered Materials lagged slightly, reflecting mixed end-market demand across chemical and specialty materials peers.
Tariff exposure flagged: management continues analyzing impacts of tariffs and potential future tariffs on the global business. Restructuring charges of $76M year-to-date reflect ongoing facility closures that could pressure near-term margins.